Most estrogen receptor modulators resemble the hormone estrogen and, although ineffective at triggering ER mediated transcription, bind to the estrogen receptor instead of the hormone to prevent breast cancer cells from proliferating4. This evidence concerns the gene ESR1 and breast carcinoma.